9DQH image
Entry Detail
PDB ID:
9DQH
EMDB ID:
Title:
CryoEM structure of Gq-coupled MRGPRD with a new agonist EP-2825
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2024-09-24
Release Date:
2024-12-11
Method Details:
Experimental Method:
Resolution:
2.92 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Mas-related G-protein coupled receptor member D
Chain IDs:A
Chain Length:322
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Gs-mini-Gq chimera
Chain IDs:B
Chain Length:246
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
Chain IDs:C
Chain Length:345
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
Chain IDs:D
Chain Length:71
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:scFv16
Chain IDs:E
Chain Length:257
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
High-affinity agonists reveal recognition motifs for the MRGPRD GPCR.
Cell Rep 43 114942 114942 (2024)
PMID: 39580805 DOI: 10.1016/j.celrep.2024.114942

Abstact

The human MRGPRD protein is a member of the Mas-related G protein-coupled receptors (MRGPRs) that is involved in the sensing of pain, itch, and other inflammatory stimuli. As with other MRGPRs, MRGPRD is a relatively understudied receptor with few known agonists. The most potent small-molecule agonist of MRGPRD reported so far is β-alanine, with an affinity in the micromole range, which largely restricts its functional study. Here, we report two MRGPRD agonists, EP-2825 and EP-3945, that are approximately 100-fold more potent than β-alanine and determine the structures of MRGPRD-Gq in complex with EP-2825 and EP-3945, respectively. The structures reveal distinct agonist binding modes of MRGPRD and large conformational plasticity of the orthosteric pocket. Collectively, the discovery of high-affinity MRGPRD agonists and their distinct binding modes will facilitate the functional study and the structure-based design of ligands targeting this understudied receptor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures